OR03-07 Real-World Effectiveness and Safety of Recombinant Human IGF-1 Treatment in Naïve Prepubertal Patients with Severe Primary IGF-I Deficiency at Near-Adult Height: Results from the Global IGFD Registry

Authors

Mohamad Maghnie (ORCID: https://orcid.org/0000-0002-7183-5238)
Marta Ramon‐Krauel (ORCID: https://orcid.org/0000-0003-3027-9105)
Peter Bang (ORCID: https://orcid.org/0009-0004-2240-6711)
Caroline Sert
Jean De Schepper (ORCID: https://orcid.org/0000-0002-2999-0250)
Artur Bossowski (ORCID: https://orcid.org/0000-0002-6316-5342)
Joachim Woelfle (ORCID: https://orcid.org/0000-0002-9132-6174)
Jesús Argente (ORCID: https://orcid.org/0000-0001-5826-0276)
Philippe Backeljauw (ORCID: https://orcid.org/0000-0003-2398-9520)
Michel Polak
Valérie Perrot (ORCID: https://orcid.org/0000-0002-5541-728X)

Linköping University (SE)
Cincinnati Children's Hospital Medical Center (US)
Hôpital Necker-Enfants Malades (FR)
Hospital Sant Joan de Déu Barcelona (ES)
Medical University of Białystok (PL)
Inserm (FR)
Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
Ipsen (France) (FR)
Université Paris Cité (FR)
Instituto de Salud Carlos III (ES)
Istituto Giannina Gaslini (IT)
Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
Hospital Infantil Universitario Niño Jesús (ES)
ERN GUARD-Heart (NL)
IMDEA Food (ES)
Istituti di Ricovero e Cura a Carattere Scientifico (IT)
University of Cincinnati (US)
Universidad Autónoma de Madrid (ES)
University of Genoa (IT)
Mathys (Netherlands) (NL)